课题基金 / 基金详情

REDUCED PHOSPHATE INTAKE IN NORMO-PHOSPHATEMIC CHRONIC KIDNEY DISEASE PATIENTS

REDUCED PHOSPHATE INTAKE IN NORMO-PHOSPHATEMIC CHRONIC KIDNEY DISEASE PATIENTS
减少正磷酸盐慢性肾病患者的磷酸盐摄入量
批准号：
7607099
负责人：
MYLES S WOLF
金额：
$0.1万
依托单位：
MASSACHUSETTS GENERAL HOSPITAL
依托单位国家：
美国
项目类别：
财政年份：
2006
资助国家：
美国
项目状态：
已结题
起止时间：
2006-12-01 至 2007-11-30
来源：
https://reporter.nih.gov/project-details/7607099
关键词：
BloodChronic Kidney FailureComputer Retrieval of Information on Scientific Projects DatabaseDevelopmentFundingGrantInstitutionInsulinIntakeKidneyPatientsPhosphorusPlayPurposeRegulationResearchResearch PersonnelResourcesRoleSecondary HyperparathyroidismSourceUnited States National Institutes of Healthinorganic phosphate

项目摘要

项目成果

MYLES S WOLF的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purposes of this proposal are to (1) establish the primacy of phosphate loading, even without hyperphosphatemia, in the development of secondary hyperparathyroidism and (2) understand what role insulin may play in kidney regulation of blood phosphorus levels.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tissue-Specific Regulation and Effects of CYP24A1
  • 批准号：
    10580931
  • 项目类别：
  • 资助金额：
    $54.75万
  • 财政年份：
    2023
  • 负责人：
    MYLES S WOLF
  • 依托单位：
    DUKE UNIVERSITY
HiLo
  • 批准号：
    10468020
  • 项目类别：
  • 资助金额：
    $129.83万
  • 财政年份：
    2019
  • 负责人：
    MYLES S WOLF
  • 依托单位：
    DUKE UNIVERSITY
HiLo
  • 批准号：
    10229378
  • 项目类别：
  • 资助金额：
    $132.8万
  • 财政年份：
    2019
  • 负责人：
    MYLES S WOLF
  • 依托单位：
    DUKE UNIVERSITY
HiLo
  • 批准号：
    9753568
  • 项目类别：
  • 资助金额：
    $144.42万
  • 财政年份：
    2019
  • 负责人：
    MYLES S WOLF
  • 依托单位：
    DUKE UNIVERSITY
海外基金